NPPB and pulmonary arterial hypertension: SERAPHIN hemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on hemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [26]